Brenton said the company is changing its guidance approach: “we have decided to withdraw our full year financial guidance at this time,” citing “the timing and scope of potential monetization actions ...
The global sugar reduction and taste modulation market is estimated at approximately USD 1.8 billion in 2025, with expected annual growth of 6–7%, driven by regulatory pressure and shifting consumer ...
Lev’s reporting has explored Americans’ deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, ...
It’s long been known that social media technology and the platforms that support it have significant addictive qualities. These include obsessive thoughts, compulsive engagement, progressively ...
Section 1. Purpose. This order continues the reduction in the elements of the Federal bureaucracy that the President has determined are unnecessary. Sec. 2. Reducing the Scope of the Federal ...
Daniel is a News Writer from the United Kingdom. Relatively new to the industry with just over three years of experience, he has focused on establishing himself in the gaming space, with bylines in ...
Forbes contributors publish independent expert analyses and insights. Sarah Sinclair is an award-winning journalist covering cannabis. The cannabis beverage market has seen significant growth in the U ...
FORT LAUDERDALE, Fla., Jan. 22, 2026 /PRNewswire/ -- Spinal Resources Inc. received a Notice of Allowability from the United States Patent and Trademark Office Inc. expanding the usage of its Bezier ...
Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...
TL;DR: Paradox Interactive has taken a $37.4 million write-down on Vampire: The Masquerade - Bloodlines 2 due to poor sales performance, significantly below expectations. The publisher will still ...
SAN FRANCISCO — Most patients with generalized myasthenia gravis (gMG) who took efgartigimod for 18 months managed to cut their glucocorticoid use to low levels or stopped taking it entirely, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results